Compare CCEL & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | ZGM |
|---|---|---|
| Founded | 1989 | 2019 |
| Country | United States | Macau |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 30.0M |
| IPO Year | 1997 | 2025 |
| Metric | CCEL | ZGM |
|---|---|---|
| Price | $3.50 | $2.32 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 26.9K |
| Earning Date | 10-15-2025 | 02-08-2026 |
| Dividend Yield | ★ 11.43% | N/A |
| EPS Growth | N/A | ★ 401.52 |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $31,747,500.00 | $3,620,780.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.37 |
| Revenue Growth | N/A | ★ 211.78 |
| 52 Week Low | $3.45 | $1.90 |
| 52 Week High | $8.79 | $4.51 |
| Indicator | CCEL | ZGM |
|---|---|---|
| Relative Strength Index (RSI) | 38.36 | N/A |
| Support Level | $3.58 | N/A |
| Resistance Level | $3.99 | N/A |
| Average True Range (ATR) | 0.30 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 3.90 | 0.00 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.